21 kilo bases encoding an mRNA of 4052 nucleotides. [5, 6] Several polymorphisms of eNOS gene are found to be associated with increased risk for CVD. Of these 894 G greater than T variant in exon 7 is reported to be associated with CAD [7, 8] while 786 T greater than C polymorphism has been associated with Hypertension; [9] and with coronary spasm. [10] It is considered a risk factor for CAD in Caucasians. [11] A 27 bp VNTR located in intron 4 of eNOS gene was proven to be of equal interest. Wang et al. [12] The authors have designated these alleles as eNOS 4a for shorter allele with four repeats and eNOS 4b for larger allele with Þ ve repeats. The study also showed that homozygosity for allele 4a had higher risk for CAD among smokers.
Other studies on eNOS intron 4 polymorphism showed positive association with renal disease [13, 14] essential hypertension among Japanese [15] and stroke among Chinese. [16] However, studies from Taiwan [17] did not reveal any association with premature CAD.
The discrepancy in these studies on the association of [1, 2] and inhibits the adhesion, and recruitment of platelets, [3, 4] 
Materials and Methods

Study subjects
The 
Analysis of VNTR Polymorphism of eNOS
Genomic DNA was extracted from peripheral blood leukocytes by non-enzymatic method. [18] Genotypes for eNOS polymorphism were determined by polyacrylamide gel electrophoresis after PCR ampliÞ cation (Biometra, Germany) of the target region.
The primers used for amplification were forward of eNOS gene. [13] Each reaction mixture was heated to initial denautrarion of 94°C for 4 minutes with 35 cycles of denaturation at 94°C for 1 minute, annealing at 56°C
for one minute, extension at 72°C for two minutes and a Þ nal extension at 74°C for seven minutes.
The PCR products were run on eight per cent PAGE gels (Biotech, Indigenous), and the fragments separated were visualized by ethidium bromide staining under UV trans-illumination. PCR analysis of genomic DNA generated fragments of 393 bps corresponding to 4a/a homozygotes, 420 bp to 4b/b homozygotes and 393 and 420 bp 4b/a heterozygote [ Figure 1 ].
The data was analyzed using descriptive statistics for epidemiological parameters and test of signiÞ cance and odds ratio estimation to evaluate the risk of VNTR genotypes at eNOS locus in terms of association with hypertension. 
Results
Discussion
It was demonstrated that 27bp repeat in the eNOS gene could bind nuclear proteins as an enhancer/repressor to promote/suppress the transcription efÞ ciency. [19] Functional signiÞ cance of this polymorphism was also identiÞ ed in cases with endothelial dysfunction. [20] In the present study the frequency of 4a allele was found to be approximately 0.16, which is little higher than that found in other populations viz., Iranian (0.1), Japanese (0.1 to 0.13) and Turkish (0.14)
but is slightly lower than in Australian (0.17) and African Americans (0.26). [21] The differences in the ethnic origin and sample sizes studied might have caused the differences in the distribution of eNOS intron 4a polymorphism studied in these populations. With reference to diseases Wang et al. [12] showed a significant association of eNOS polymorphism with CAD in smokers but not with hypertension.
Uwabo et al. [15] have shown a signiÞ cant association of hypertension with a/a homozygosity among the Japanese.
They also suggested that this VNTR polymorphism may be in linkage disequilibrium with other genes related to essential hypertension. The report of Ichihara et al, [22] and
Salimi et al., [21] have shown a positive association of eNOS 4b/a polymorphism with CAD in Japanese and Iranian populations. Absence of such association was reported in
German and Taiwanese populations. [23, 17] Though this study did not reveal signiÞ cant association of eNOS intron4 polymorphism with essential hypertension in general, males with carriers for allele 'a' did show a signiÞ cant risk for the condition which was Þ ve times higher compared to other genotypes. Further, individuals who were obese, with positive family history, and non-vegetarian food habits were also at risk as evidenced by the high occurrence of hypertensives in these groups. Contribution of these risk factors has to be evaluated with large samples and cohorts of confounding factors.
